Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $828 - $999
-5 Reduced 0.25%
2,022 $342,000
Q4 2023

Feb 14, 2024

SELL
$151.44 - $200.09 $11,812 - $15,607
-78 Reduced 3.71%
2,027 $400,000
Q3 2023

Nov 09, 2023

SELL
$167.14 - $192.77 $5,849 - $6,746
-35 Reduced 1.64%
2,105 $366,000
Q2 2023

Jul 25, 2023

BUY
$160.94 - $186.23 $344,411 - $398,532
2,140 New
2,140 $368,000
Q4 2022

Feb 02, 2023

SELL
$131.14 - $157.47 $4,065 - $4,881
-31 Reduced 1.37%
2,233 $327,000
Q3 2022

Oct 31, 2022

BUY
$148.29 - $182.55 $335,728 - $413,293
2,264 New
2,264 $336,000
Q2 2022

Aug 05, 2022

SELL
$155.97 - $200.09 $408,173 - $523,635
-2,617 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $474,697 - $612,456
2,617 New
2,617 $494,000
Q4 2021

Feb 02, 2022

SELL
$193.69 - $247.03 $543,881 - $693,660
-2,808 Closed
0 $0
Q3 2021

Oct 21, 2021

BUY
$189.29 - $209.69 $8,707 - $9,645
46 Added 1.67%
2,808 $545,000
Q2 2021

Jul 20, 2021

SELL
$155.9 - $187.99 $31,024 - $37,410
-199 Reduced 6.72%
2,762 $515,000
Q1 2021

Apr 27, 2021

BUY
$144.0 - $169.39 $426,384 - $501,563
2,961 New
2,961 $467,000
Q4 2020

Jan 29, 2021

SELL
$157.07 - $174.35 $774,826 - $860,068
-4,933 Closed
0 $0
Q3 2020

Oct 23, 2020

BUY
$137.1 - $165.37 $97,341 - $117,412
710 Added 16.81%
4,933 $816,000
Q2 2020

Jul 20, 2020

BUY
$111.92 - $142.53 $671 - $855
6 Added 0.14%
4,223 $579,000
Q1 2020

Apr 22, 2020

SELL
$92.66 - $144.94 $28,353 - $44,351
-306 Reduced 6.77%
4,217 $496,000
Q4 2019

Jan 30, 2020

SELL
$116.25 - $133.25 $8,835 - $10,127
-76 Reduced 1.65%
4,523 $599,000
Q3 2019

Oct 28, 2019

SELL
$112.57 - $128.43 $95,797 - $109,293
-851 Reduced 15.61%
4,599 $573,000
Q2 2019

Aug 08, 2019

SELL
$97.98 - $114.28 $5,192 - $6,056
-53 Reduced 0.96%
5,450 $619,000
Q1 2019

May 01, 2019

BUY
$81.56 - $100.67 $448,824 - $553,987
5,503 New
5,503 $554,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Concorde Asset Management, LLC Portfolio

Follow Concorde Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concorde Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concorde Asset Management, LLC with notifications on news.